Cimatron Reports Best Ever Third Quarter with Record Q3 Revenues, Operating Profit and Net Profit

GIVAT SHMUEL, Israel, Nov. 12, 2013 /PRNewswire/ -- Cimatron Limited (NASDAQ: CIMT), a leading provider of integrated CAD/CAM software solutions for the toolmaking and manufacturing industries, today announced financial results for the third quarter and first nine months of 2013. 

Highlights of Cimatron's results for the third quarter of 2013 include the following:

  • 45% increase in y-o-y non-GAAP operating profit, to a Q3 record of $1.4 million
  • 62% increase in y-o-y non-GAAP net profit, to a Q3 record of $1.1 million
  • Record Q3 revenues of $10.3 million, a 9% y-o-y increase (6% in constant currencies)
  • 88% gross margin and 14% operating margin on a non-GAAP basis
  • $0.11 non-GAAP EPS
  • $12.9 million end of quarter net cash balance

Commenting on the results, Danny Haran, President and Chief Executive Officer of Cimatron, noted, "We are very pleased to report Q3/13 as a record third quarter in practically all parameters. In particular, we are pleased that the year-over-year revenue growth in the quarter was translated to significant year-over-year growth in operating and net profits.

"We remain faithful to our long term product strategy, striving to bring ever more value to our customers via internal development as well as through new third party partnerships. Our recent agreement with MachineWorks, to incorporate their Polygonica software inside CimatronE, is a perfect example. We believe that our enhanced investment in R&D, as well as in sales and marketing, will support further revenue and profit growth going forward. In parallel, we continue to explore M&A opportunities, where synergy can be found in terms of product, technology or distribution channels," concluded Mr. Haran.

The following provides details on Cimatron's GAAP and non-GAAP results for the third quarter and first nine months of 2013:

GAAP:

Revenues for the third quarter of 2013 were $10.3 million, compared to $9.5 million recorded in the third quarter of 2012. For the first nine months of 2013, revenues were $31.5 million, compared to $30.0 million in the same period of 2012. 

Gross Profit for the third quarter of 2013 was $8.9 million, as compared to $8.2 million in the same period in 2012. Gross margin in the third quarter of 2013 was 86% of revenues, compared to 87% in the third quarter of 2012. For the first nine months of 2013, gross profit was $27.4 million, compared to $26.4 million in the same period of 2012. Gross margin for the nine months ended September 30, 2013 was 87% of revenues, compared to a gross margin of 88% of revenues for the first nine months of 2012.

The higher gross margin in the first nine months of 2012 as compared to the parallel period of 2013 mainly reflect the agreement with the Office of Chief Scientist in the Israeli Ministry of Industry, Trade and Labor (OCS), that was announced last year. As a result of that agreement, the Company recorded an additional one-time income of approximately $0.4 million in the second quarter of 2012, reflected as a lower cost of revenue in the GAAP Statements of Income for the first nine months of 2012. Such income was excluded from the non-GAAP results for the first nine months of 2012, in order to ensure that comparisons to comparable periods of previous years better reflect the results of ongoing operations.

Operating Profit in the third quarter of 2013 increased 70% to $1.2 million, as compared to $0.7 million in the same period of 2012. In the first nine months of 2013, Cimatron recorded an operating profit of $3.4 million, the same as in the first nine months of 2012. 

Net Profit for the third quarter of 2013 increased 83% to $1.0 million, or $0.10 per diluted share, compared to a net profit of $0.5 million, or $0.06 per diluted share, recorded in the same quarter of 2012.  In the first nine months of 2013, net profit was $2.6 million, or $0.27 per diluted share, compared to a net profit of $2.4 million, or $0.25 per diluted share, in the first nine months of 2012. 

Non-GAAP:

Revenues for the third quarter of 2013 were $10.3 million, compared to $9.5 million recorded in the third quarter of 2012. For the first nine months of 2013, revenues were $31.5 million, compared to $30.0 million in the same period of 2012. 

Gross Profit for the third quarter of 2013 was $9.0 million, as compared to $8.4 million in the same period of 2012. Gross margin in the third quarter of 2013 was 88% of revenues, compared to 89% in the third quarter of 2012. In the first nine months of 2013, gross profit was $27.8 million, compared to $26.4 million in the first nine months of 2012. Gross margin for the nine months ended September 30, 2013 was 88% of revenues, the same as in the first nine months of 2012.

Operating Profit in the third quarter of 2013 increased 45% to $1.4 million, as compared to $1.0 million in the same period in 2012. In the first nine months of 2013, Cimatron recorded an operating profit of $4.0 million, compared to an operating profit of $3.8 million in the first nine months of 2012.

Net Profit for the third quarter of 2013 increased 62% to $1.1 million, or $0.11 per diluted share, compared to a net profit of $0.7 million, or $0.07 per diluted share, recorded in the same quarter of 2012. In the first nine months of 2013, net profit was $3.0 million, or $0.32 per diluted share, compared to a net profit of $2.7 million, or $0.29 per diluted share, in the first nine months of 2012.


Conference Call

Cimatron's management will host a conference call today, November 12, 2013, at 9:00 EST, 16:00 Israel time. On the call, management will review and discuss the results, and will answer questions by investors.

To participate, please call one of the following teleconferencing numbers. Please begin placing your call at least 5 minutes before the conference call commences.

USA: +1-888-668-9141
International: +972-3-9180610
Israel: 03-9180610

For those unable to listen to the live call, a replay of the call will be available beginning on the day after the call at the investor relations section of Cimatron's website, at: www.cimatron.com

Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income included herein. Non-GAAP financial measures consist of GAAP financial measures adjusted to include recognition of deferred revenues of acquired companies and to exclude amortization of acquired intangible assets and deferred income tax, as well as certain business combination and other accounting entries. The purpose of such adjustments is to give an indication of our performance exclusive of non-cash charges and other items that are considered by management to be outside of our core operating results. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP. Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. We believe that these non-GAAP measures help investors to understand our current and future operating performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies.

About Cimatron

With over 30 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM software solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles and ultimately shorten product delivery time.

The Cimatron product line includes the CimatronE and GibbsCAM brands with software solutions for mold design, die design, electrode design, 2.5 to 5 Axis milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.

Cimatron's shares are publicly traded on the NASDAQ under the symbol CIMT. For more information, please visit Cimatron's web site at: http://www.cimatron.com

Safe Harbor Statement

This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron's business, refer to Cimatron's filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

 

CIMATRON LIMITED

CONSOLIDATED STATEMENTS OF INCOME

(US Dollars in thousands, except for per share data)




















Three months ended


Nine months ended







September 30,


September 30,







2013


2012


2013


2012














Total revenue

10,301


9,463


31,498


29,957














Total cost of revenue

1,405


1,218


4,122


3,570

Gross profit

8,896


8,245


27,376


26,387














   Research and development expenses

1,790


1,613


5,276


4,935














   Selling, general and administrative expenses

5,891


5,918


18,694


18,019

Operating income 

1,215


714


3,406


3,433














   Financial income (expenses), net

15


41


(9)


(51)














   Taxes on income

(265)


(199)


(834)


(999)














   Other


(1)


(18)


4


(7)

Net income 

964


538


2,567


2,376














   Less: Net income attributable to the noncontrolling interest

(9)


(15)


(6)


(24)














Net income attributable to Cimatron's shareholders

$ 955


$ 523


$ 2,561


$ 2,352

Net income per share - basic and diluted

$ 0.10


$ 0.06


$ 0.27


$ 0.25














Weighted average number of shares outstanding






















Basic EPS (in thousands)

9,727


9,314


9,480


9,308















Diluted EPS (in thousands)

9,740


9,331


9,488


9,325

 

CIMATRON LIMITED

RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION

(US Dollars in thousands, except for per share data)




































Three months ended


Nine months ended







September,


September,







2013


2012


2013


2012







GAAP


Adj.


NON-GAAP


GAAP


Adj.


NON-GAAP


GAAP


Adj.


NON-GAAP


GAAP


Adj.


NON-GAAP






























Total revenue 

10,301


-


10,301


9,463


-


9,463


31,498


-


31,498


29,957


-


29,957






























Total cost of revenue 

1,405




1,258


1,218




1,071


4,122




3,681


3,570




3,548


Non-cash amortization of acquired intangible assets



(147)






(147)






(441)






(441)




One-time income from OCS agreement





















419



Gross profit

8,896


147


9,043


8,245


147


8,392


27,376


441


27,817


26,387


22


26,409






























   Research and development expenses (1)

1,790


(3)


1,787


1,613


-


1,613


5,276


(3)


5,273


4,935


-


4,935






























   Selling, general and administrative expenses

5,891




5,861


5,918




5,819


18,694




18,579


18,019




17,723


Non-cash amortization of acquired intangible assets



-






(99)






(85)






(296)




Stock-based compensation



(30)






-






(30)






-



Operating income 

1,215


180


1,395


714


246


960


3,406


559


3,965


3,433


318


3,751






























   Financial income (expenses), net

15


-


15


41


-


41


(9)


-


(9)


(51)


-


(51)






























   Taxes on income (2)

(265)


(34)


(299)


(199)


(90)


(289)


(834)


(125)


(959)


(999)


28


(971)






























   Other 

(1)


-


(1)


(18)


-


(18)


4


-


4


(7)


-


(7)






























Net income 

964


146


1,110


538


156


694


2,567


434


3,001


2,376


346


2,722






























   Less: Net income attributable to the noncontrolling interest

(9)


-


(9)


(15)


-


(15)


(6)


-


(6)


(24)


-


(24)






























Net income attributable to Cimatron's shareholders

$ 955


$ 146


$ 1,101


$ 523


$ 156


$ 679


$ 2,561


$ 434


$ 2,995


$ 2,352


$ 346


$ 2,698

Net income per share - basic and diluted 

$ 0.10




$ 0.11


$ 0.06




$ 0.07


$ 0.27




$ 0.32


$ 0.25




$ 0.29

























Weighted average number of shares outstanding

















































Basic EPS (in thousands)

9,727




9,727


9,314




9,314


9,480




9,480


9,308




9,308


























Diluted EPS (in thousands)

9,740




9,740


9,331




9,331


9,488




9,488


9,325




9,325






































































(1) Non-GAAP adjustment to exclude stock-based compensation


















(2) Non-GAAP adjustment to exclude the effect of deferred taxes and other tax provisions.















































 

CIMATRON LIMITED

CONSOLIDATED BALANCE SHEETS

(US Dollars in thousands)


















September 30,


December 31,








2013


2012
















ASSETS





CURRENT ASSETS:






Total cash, cash equivalents and short-term investments


$          12,914


$        11,903


Trade receivables


5,457


6,049


Other current assets


2,033


1,788



Total current assets


20,404


19,740























Deposits with insurance companies and severance pay fund


3,624


3,296













Net property and equipment


964


875













Net other assets


10,057


10,499














Total assets


$          35,049


$        34,410
















LIABILITIES AND SHAREHOLDERS' EQUITY





CURRENT LIABILITIES:






Short-term bank credit


$                21


$                1


Trade payables


1,023


1,169


Accrued expenses and other liabilities


5,059


7,204


Deferred revenues


4,802


2,843



Total current liabilities


10,905


11,217











LONG-TERM LIABILITIES:






Accrued severance pay


4,889


4,453


Deferred tax liability


127


275


   Total long-term liabilities


5,016


4,728












Total shareholders' equity


19,128


18,465




Total liabilities and shareholders' equity


$          35,049


$        34,410





















        

CIMATRON LIMITED

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY 

(US Dollars in thousands)
























Accumulated other comprehensive income (loss)






Comprehensive income (loss)



Noncontrolling Interest


Share capital


Additional paid-in capital



Retained earnings (accumulated deficit)


Treasury stock



Total shareholders' equity

Balance at December 31, 2012

$                28


$         313


$     18,906


$                   (6)


$               (24)


$        (752)




$         18,465

Changes during the nine months ended
  September 30, 2013:
















Net income

6








2,561




2,567


2,567

Cash distribution to shareholders





(7,916)










(7,916)

Issuance of shares



28


5,758










5,786

Issuance of restricted shares



9












9

Stock based compensation





80










80

Other  







73






73


73

Foreign currency translation adjustment







64






64


64

Total comprehensive income













2,704



Balance at September 30, 2013

$                34


$         350


$     16,828


$                131


$           2,537


$        (752)




$         19,128





CIMATRON LIMITED

STATEMENTS OF CASH FLOWS

(US Dollars in thousands)












Nine months ended





September 30,





2013


2012








Cash flows from operating activities:




Net income 

$        2,567


$        2,376








Adjustments to reconcile net income 




   to net cash provided by operating activities:




Depreciation and amortization

796


1,007

Increase in accrued severance pay

415


63

Stock based compensation

33


-

Deferred taxes, net

(115)


(272)








Changes in assets and liabilities:




Decrease in accounts receivable and prepaid expenses

332


1,051

Increase (decrease) in inventory

12


(2)

Increase in deposits with insurance companies and severance pay fund

(328)


(63)

Decrease in trade payables, accrued expenses and other liabilities

(425)


(1,587)

Net cash provided by operating activities

3,287


2,573








Cash flows from investing activities:




Proceeds from sale of property and equipment

-


1

Purchase of property and equipment

(346)


(243)

Net cash used in investing activities

(346)


(242)















Cash flows from financing activities:




Short-term bank credit

20


(40)

Long-term bank credit

(3)


(7)

Cash distribution to shareholders

(7,916)


(1,863)

Proceeds from issuance of shares upon exercise of options 

47


40

Proceeds from issuance of restricted shares

9


-

Proceeds from issuance of shares 

5,786


-

Net cash used in financing activities

(2,057)


(1,870)















Net increase in cash and cash equivalents

884


461

Effect of exchange rate changes on cash

127


28

Cash and cash equivalents at beginning of period

11,903


11,787

Cash and cash equivalents at end of period

$      12,914


$      12,276








Appendix A - Non-cash transactions





Purchase of property on credit

$              7


$              5















 

Company Contact:

Investor Relations contact

Ilan Erez, Chief Financial Officer

Ehud Helft/Kenny Green

Cimatron Ltd.

CCG Investor Relations

Tel.; 972-73-237-0114

Tel: (US) 1 646 201 9246

Email: ilane@cimatron.com

Email: Cimatron@ccgisrael.com

SOURCE Cimatron



RELATED LINKS
http://www.cimatron.com

More by this Source

Best of Content We Love 2014 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.